Viemed Healthcare (NASDAQ:VMD) Stock Rating Lowered by Freedom Capital

Viemed Healthcare (NASDAQ:VMD) was downgraded by equities researchers at Freedom Capital from a “strong-buy” rating to a “hold” rating in a research report issued on Wednesday,Zacks.com reports.

Separately, Weiss Ratings raised Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Viemed Healthcare currently has a consensus rating of “Hold”.

Viemed Healthcare Stock Performance

NASDAQ:VMD opened at $9.52 on Wednesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.13 and a quick ratio of 1.10. The firm has a market cap of $362.62 million, a PE ratio of 26.45 and a beta of 1.10. The firm has a 50 day simple moving average of $11.15 and a 200-day simple moving average of $9.75. Viemed Healthcare has a 1-year low of $6.05 and a 1-year high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last announced its earnings results on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.05). The firm had revenue of $78.10 million for the quarter, compared to analyst estimates of $78.00 million. Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%. On average, equities analysts expect that Viemed Healthcare will post 0.44 EPS for the current year.

Insider Transactions at Viemed Healthcare

In other news, Director Timothy Smokoff sold 20,000 shares of the stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the transaction, the director directly owned 75,518 shares in the company, valued at $868,457. This represents a 20.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider William Frazier sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the sale, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 20.60% of the company’s stock.

Institutional Trading of Viemed Healthcare

Institutional investors have recently made changes to their positions in the stock. Arrowstreet Capital Limited Partnership increased its position in Viemed Healthcare by 101.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after purchasing an additional 358,863 shares in the last quarter. Wasatch Advisors LP lifted its position in Viemed Healthcare by 18.4% during the second quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock valued at $10,683,000 after buying an additional 240,346 shares in the last quarter. Hillsdale Investment Management Inc. purchased a new stake in Viemed Healthcare during the first quarter worth approximately $1,834,000. Two Sigma Investments LP grew its stake in Viemed Healthcare by 193.7% during the third quarter. Two Sigma Investments LP now owns 251,410 shares of the company’s stock worth $1,707,000 after buying an additional 165,797 shares during the period. Finally, Rothschild Wealth LLC acquired a new stake in shares of Viemed Healthcare in the fourth quarter worth $967,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.